Generating evidence for new high-risk medical devices

被引:7
|
作者
Campbell, Bruce [1 ]
Wilkinson, John [2 ]
Marlow, Mirella [3 ]
Sheldon, Murray [4 ]
机构
[1] Univ Exeter, Med Sch, Exeter, Devon, England
[2] Med & Healthcare Prod Regulatory Agcy MHRA, London, England
[3] Natl Inst Hlth & Care Excellence NICE, London, England
[4] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA
关键词
technology; HEALTH TECHNOLOGY-ASSESSMENT; CHALLENGES; QUALITY;
D O I
10.1136/bmjsit-2019-000022
中图分类号
R61 [外科手术学];
学科分类号
摘要
[No abstract available]
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Scientific Evidence in Health Technology Assessment Reports: An In-Depth Analysis of European Assessments on High-Risk Medical Devices
    Olberg, Britta
    Fuchs, Sabine
    Panteli, Dimitra
    Perleth, Matthias
    Busse, Reinhard
    VALUE IN HEALTH, 2017, 20 (10) : 1420 - 1426
  • [32] Fraud in medical and scientific publications: A new high-risk pandemic?
    Salomona, Laurent J.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2025, 53 (03): : 115 - 117
  • [33] Examining the National Regulatory Environment of Medical Devices: Major Issues in the Risk-Benefit Assessment of High-Risk Devices
    Mathieu, Ghislaine
    Williams-Jones, Bryn
    MCGILL JOURNAL OF LAW AND HEALTH, 2015, 9 (01): : 17 - 68
  • [34] An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and recommendations
    Tarricone, Rosanna
    Banks, Helen
    Ciani, Oriana
    Brouwer, Werner
    Drummond, Michael F.
    Leidl, Reiner
    Martelli, Nicolas
    Sampietro-Colom, Laura
    Taylor, Rod S.
    EXPERT REVIEW OF MEDICAL DEVICES, 2023, 20 (04) : 259 - 271
  • [35] EVIDENCE FOR HIGH RISK CLASS MEDICAL DEVICES VERSUS NEW DRUGS IN GERMANY: WHAT'S THE DIFFERENCE?
    Mueller, E.
    Neeser, K.
    Oelze, I
    VALUE IN HEALTH, 2018, 21 : S157 - S158
  • [36] QUALITY OF SAMPLE SIZE ESTIMATION IN TRIALS OF MEDICAL DEVICES: HIGH-RISK DEVICES FOR NEUROLOGICAL CONDITIONS AS EXAMPLE
    Olberg, Britta
    Perleth, Matthias
    Felgentraeger, Katja
    Schulz, Sandra
    Busse, Reinhard
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2017, 33 (01) : 103 - 110
  • [37] Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011
    Rathi, Vinay K.
    Krumholz, Harlan M.
    Masoudi, Frederick A.
    Ross, Joseph S.
    JAMA NETWORK OPEN, 2020, 3 (08)
  • [38] Clinical evidence for high-risk CE-marked medical devices for glucose management: A systematic review and meta-analysis
    Bano, Arjola
    Kunzler, Juri
    Wehrli, Faina
    Kastrati, Lum
    Rivero, Tania
    Llane, Adea
    Gris, Angelica Valz
    Fraser, Alan G.
    Stettler, Christoph
    Hovorka, Roman
    Laimer, Markus
    Bally, Lia
    DIABETES OBESITY & METABOLISM, 2024, 26 (10): : 4753 - 4766
  • [39] Physician-Patient Communication about Novel Drugs and High-Risk Medical Devices
    Dhruva, Sanket S.
    Kesselheim, Aaron S.
    Woloshin, Steven
    Ji, Robin Z.
    Lu, Zhigang
    Darrow, Jonathan J.
    Redberg, Rita F.
    MEDICAL DECISION MAKING, 2025, 45 (02) : 156 - 167
  • [40] High-Risk Medical Devices Why Do We Not Better Understand Effectiveness and Safety?
    Ross, Joseph S.
    JAMA INTERNAL MEDICINE, 2015, 175 (06) : 939 - 940